A proof-of concept open-label randomized clinical trial has also assessed the effect of GLP-1R agonists on 46 patients with T2D and mild to moderate diabetic peripheral neuropathy (Jaiswal et al., 2015)
The transition from 0.5 mg to 1 mg is where many patients notice the 'sweet spot'sufficient appetite suppression to maintain a calorie deficit without overwhelming gastrointestinal effects
SURMOUNT-1 tirzepatide obesity trial Trial Primary trial source for tirzepatide weight-loss expectations and dose-response ranges
Furthermore, the T 3 hormone stimulates cardiac mitochondrial biogenesis increasing myocardial mitochondrial mass, mitochondrial respiration, oxidative phosphorylation (OXPHOS), enzyme activities, mitochondrial protein synthesis (stimulated through T 3 ), cytochrome, phospholipid, and mtDNA content [79]
Thus far, the aggregate impact on consumption is moderate, therefore mitigating the total impact on F&B players
Choosing natural, whole food alternatives and natural sweeteners is a safer and healthier option if you are looking for some sweetness